Stem cells in the treatment of patients with coronary heart disease. Part I

被引:1
|
作者
Zhukova, N. S.
Staroverov, I. I.
机构
[1] Russian Cardiology Scientific and Clinical Complex, Moscow
来源
CARDIOVASCULAR THERAPY AND PREVENTION | 2011年 / 10卷 / 02期
关键词
Myocardial infarction; ischemic cardiomyopathy; stem cells; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; ACUTE MYOCARDIAL-INFARCTION; AUTOLOGOUS SKELETAL MYOBLASTS; ENHANCES COLLATERAL PERFUSION; CARDIAC STEM; REGENERATION ENHANCEMENT; ISCHEMIC MYOCARDIUM; REGIONAL FUNCTION; STATIN THERAPY;
D O I
10.15829/1728-8800-2011-2-122-128
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) is one of the leading death causes in patients with myocardial infarction (MI). The modern methods of reperfusion MI therapy, such as thrombolysis, surgery and balloon revascularization, even when performed early, could fail to prevent the development of large myocardial damage zones, followed by HE Therefore, the researches have been searching for the methods which improve functional status of damaged myocardium. This review is focused on stem cell therapy, a method aimed at cardiac function restoration. The results of experimental and clinical studies on stem cell therapy in coronary heart disease are presented. Various types of stem cells, used for cellular cardiomyoplasty, are characterised. The methods of cell transplantation into myocardium and potential adverse effects of stem cell therapy are discussed.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [1] Stem cells in treating patients with coronary heart disease. Part II. Bone marrow-derived mononuclear cells
    Zhukova, N. S.
    Staroverov, I. I.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (05): : 99 - 105
  • [2] Optimization of treatment of patients with arterial hypertension in combination with coronary heart disease.
    Sheiko, S. O.
    Kolb, N. O.
    MEDICAL PERSPECTIVES-MEDICNI PERSPEKTIVI, 2018, 23 (02): : 119 - 125
  • [3] Cholesterol treatment levels in high risk patients for coronary heart disease.
    Ball, B
    Hopkins, PN
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 90A - 90A
  • [4] Lifestyle management for patients with coronary heart disease.
    Di Blasi, Z
    PSYCHOLOGY & HEALTH, 1998, 13 (03) : 562 - 563
  • [5] ACE inhibitors in the treatment of patients with coronary heart disease. Overview for the year 2003
    Mareev, VY
    KARDIOLOGIYA, 2003, 43 (12) : 4 - 14
  • [6] Chronic coronary heart disease. Treatment strategies for revascularization
    Russ, M.
    Fleck, E.
    Graf, K.
    Gams, E.
    Werdanl, K.
    KARDIOLOGE, 2007, 1 (01): : 55 - 67
  • [7] I/D polymorphism of the ACE gene in patients with hypertension, NIDDM and coronary heart disease.
    Chuang, LM
    Chiu, KC
    Chiang, FT
    Lee, KC
    Wu, HP
    Lin, BJ
    Tai, TY
    DIABETOLOGIA, 1997, 40 : 650 - 650
  • [8] Subgingival plaque composition of patients with coronary heart disease.
    Nonnenmacher, C.
    Stelzel, M.
    Conrads, G.
    Moosdorf, R.
    Mutters, R.
    Flores-De-Jacoby, L.
    JOURNAL OF DENTAL RESEARCH, 2003, 82 : B223 - B223
  • [9] Genetic factors and hyperhomocysteinemia in patients with Coronary Heart Disease.
    Nair, SR
    Nair, KG
    Li, S
    Ashavaid, TF
    Dalal, JJ
    CLINICAL CHEMISTRY, 1998, 44 : A127 - A128
  • [10] Stem Cells in the Treatment of Heart Disease
    Janssens, Stefan
    ANNUAL REVIEW OF MEDICINE, 2010, 61 : 287 - 300